Deaths Preventable in the U.S. by Improvements in Use of Clinical Preventive Services

American Journal of Preventive Medicine

Volumn 38, Issue 6, 2010, Pages 600-609

  Farley, Thomas A ^a   Dalal, Mehul A ^a   Mostashari, Farzad ^b   Frieden, Thomas R ^c  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b USDHHS   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HYPERTENSION; MATHEMATICAL MODEL; MORTALITY; PHARMACEUTICAL CARE; PREDICTION; PREVALENCE; PREVENTIVE HEALTH SERVICE; RISK FACTOR; UNITED STATES;

ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HEALTH CARE REFORM; HUMANS; MIDDLE AGED; MODELS, THEORETICAL; MORTALITY; PREVENTIVE HEALTH SERVICES; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS; UNITED STATES;

EID: 77952326558     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2010.02.016     Document Type: Article

References (46)

1. Ostbye T., Yarnall K.S.H., Krause K.M., Pollak K.I., Gradison M., and Michener J.L. Is there time for management of patients with chronic diseases in primary care?. Ann Fam Med 3 3 (2005) 209-214
2. Yarnall K.S.H., Pollak K.I., Ostbye T., Krause K.M., and Michener J.L. Primary care: is there enough time for prevention?. Am J Public Health 93 4 (2003) 635-641
3. McGlynn E.A., Asch S.M., Adams J., et al. The quality of health care delivered to adults in the U.S. N Engl J Med 348 26 (2003) 2635-2645
4. Maciosek M.V., Coffield A.B., Edwards N.M., Flottemesch T.J., Goodman M.J., and Solberg L.I. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 31 1 (2006) 52-61
5. Kahn R., Robertson R.M., Smith R., and Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Diabetes Care 31 8 (2008) 1686-1696
6. U.S. Census Bureau. American FactFinder. factfinder.census.gov
7. CDC, National Center for Health Statistics. Data Warehouse worktable GMWK291R: death rates for 113 selected causes by 5-year age groups, race, and sex: U.S., 1999-2005. www.cdc.gov/nchs/datawh/statab/unpubd/mortabs/gmwk291_10.htm
8. Jefferson T., and Di Pietrantonj C. Inactivated influenza vaccines in the elderly-are you sure?. Lancet 370 9594 (2007) 1199-1200
9. Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., and Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357 14 (2007) 1373-1381
10. Simonsen L., Taylor R.J., Viboud C., Miller M.A., and Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7 10 (2007) 658-666
11. CDC, National Center for Health Statistics. Health, U.S., 2007 (2008), USDHHS, Hyattsville MD
12. Ong K.L., Cheung B.M., Man Y.B., Lau C.P., and Lam K.S. Prevalence, awareness, treatment, and control of hypertension among U.S. adults 1999-2004. Hypertension 49 1 (2007) 69-75
13. Lewington S., Whitlock G., Clarke R., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370 9602 (2007) 1829-1839
14. Neal B., MacMahon S., and Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 356 9246 (2000) 1955-1964
15. Hyre A.D., Muntner P., Menke A., Raggi P., and He J. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol 17 7 (2007) 548-555
16. Mann D., Reynolds K., Smith D., and Muntner P. Trends in statin use and low-density lipoprotein cholesterol levels among U.S. adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother 42 9 (2008) 1208-1215
17. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 2 (2004) 227-239
18. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 366 9493 (2005) 1267-1278
19. Pignone M., Anderson G.K., Binns K., Tilson H.H., and Weisman S.M. Aspirin use among adults aged 40 and older in the U.S.: results of a national survey. Am J Prev Med 32 5 (2007) 403-407
20. Ajani U.A., Ford E.S., Greenland K.J., Giles W.H., and Mokdad A.H. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. Am J Prev Med 30 1 (2006) 74-77
21. Fowkes F.G., Murray G.D., Butcher I., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300 2 (2008) 197-208
22. Hayden M., Pignone M., Phillips C., and Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 136 2 (2002) 161-172
23. CDC. Behavioral Risk Factor Surveillance System Survey Data 2007. apps.nccd.cdc.gov/brfss
24. Hymowitz N., Cummings K.M., Hyland A., Lynn W.R., Pechacek T.F., and Hartwell T.D. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 6 2S (1997) S57-S62
25. Messer K., Trinidad D.R., Al-Delaimy W.K., and Pierce J.P. Smoking cessation rates in the U.S.: a comparison of young adult and older smokers. Am J Public Health 98 2 (2008) 317-322
26. Solberg L.I., Maciosek M.V., Edwards N.M., Khanchandani H.S., and Goodman M.J. Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness. Am J Prev Med 31 1 (2006) 62-71
27. Doll R., Peto R., Boreham J., and Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328 7455 (2004) 1519
28. Kenfield S.A., Stampfer M.J., Rosner B.A., and Colditz G.A. Smoking and smoking cessation in relation to mortality in women. JAMA 299 17 (2008) 2037-2047
29. Paganini-Hill A., and Hsu G. Smoking and mortality among residents of a California retirement community. Am J Public Health 84 6 (1994) 992-995
30. Taylor Jr. D.H., Hasselblad V., Henley S.J., Thun M.J., and Sloan F.A. Benefits of smoking cessation for longevity. Am J Public Health 92 6 (2002) 990-996
31. Thun M.J., Day-Lally C.A., Calle E.E., Flanders W.D., and Heath Jr. C.W. Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health 85 9 (1995) 1223-1230
32. Humphrey L.L., Helfand M., Chan B.K.S., and Woolf S.H. Breast cancer screening: a summary of the evidence. Guide to Clinical Preventive Services, 2001-2004. 3rd ed. (2004), Agency for Healthcare Research and Quality 181-210
33. U.S. Preventive Services Taskforce. Screening for cervical cancer. Guide to Clinical Preventive Services. 2nd ed. (1996), USDHHS, Office of Disease Prevention and Health Promotion, Bethesda MD 105-117
34. Shapiro J.A., Seeff L.C., Thompson T.D., Nadel M.R., Klabunde C.N., and Vernon S.W. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 17 7 (2008) 1623-1630
35. Muller A.D., and Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 155 16 (1995) 1741-1748
36. Jefferson T.O., Rivetti D., Di Pietrantonj C., Rivetti A., and Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2 (2007) CD001269
37. Rivetti D., Jefferson T., Thomas R., et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3 (2006) CD004876
38. Moberly S.A., Holden J., Tatham D.P., and Andrews R.M. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 1 (2008) CD000422
39. Vila-Corcoles A., Ochoa-Gondar O., Hospital I., et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 43 7 (2006) 860-868
40. Watson L., Wilson B.J., and Waugh N. Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. Vaccine 20 17-18 (2002) 2166-2173
41. National Committee for Quality Assurance. The State of Health Care Quality 2008 (2008) Washington DC
42. Quinn V.P., Hollis J.F., Smith K.S., et al. Effectiveness of the 5-As tobacco cessation treatments in nine HMOs. J Gen Intern Med 24 2 (2009) 149-154
43. Maciosek M.V., Coffield A.B., McGinnis J.M., et al. Methods for priority setting among clinical preventive services. Am J Prev Med 21 1 (2001) 10-19
44. Dorn S. Uninsured and dying of it: updating the IOM Analysis on the impact of uninsurance on mortality. The Urban Institute. www.urban.org/publications/411588.html
45. Dexheimer J.W., Talbot T.R., Sanders D.L., Rosenbloom S.T., and Aronsky D. Prompting clinicians about preventive care measures: a systematic review of randomized controlled trials. J Am Med Inform Assoc 15 3 (2008) 311-320
46. Frieden T.R., and Mostashari F. Health care as if health mattered. JAMA 299 8 (2008) 950-952